FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Federal Register

Info Collection Extension for Drug Supply Chain Guide

Federal Register notice: FDA has submitted to OMB an information collection extension entitled Guidance for Industry: Drug Supply Chain Security Act I...

Federal Register

InSightecs Exablate Regulatory Review Period Determined

Federal Register notice: FDA determines for patent extension purposes the regulatory review period for InSightecs medical device Exablate.

Federal Register

Info Collection Extension on Device e-Registration & Listing

Federal Register notice: FDA seeks comments on an information collection extension entitled Electronic Submission of Medical Device Registration and L...

Medical Devices

FDA Approves Olympus Device for Emphysema

FDA approves Olympus Spiration Valve System for treating severe emphysema, a progressive form of chronic obstructive pulmonary disease.

Human Drugs

Improvements to FDA Adaptive Design Guidance Praised

PHRMA praises FDA for its new draft guidance on adaptive designs for clinical trials of drugs and biologics.

Medical Devices

FDA Clears Subtle Medical AI Technology for Images

FDA clears a Subtle Medical 510(k) for the SubtlePET, an artificial intelligence-powered technology that the company says allows hospitals and imaging...

Medical Devices

FDA Clears Bausch & Lomb Astigmatism Contact Lens

FDA clears a Bausch & Lomb 510(k) for its Ultra Multifocal for Astigmatism contact lens, a monthly silicone hydrogel lens.

Human Drugs

Priority Review for Genentech Tecentriq sBLA

FDA accepts for priority review a Genentech sBLA for a new indication for its Tecentriq.

Federal Register

Regulatory Review Period for Aspire Assist Device

Federal Register notice: FDA determines for patent extension purposes the regulatory review period for Aspire Bariatrics medical device Aspire Assist....

Federal Register

Regulatory Review Period for Synergys Trulance

Federal Register notice: FDA determines for patent extension purposes the regulatory review period for Synergy Pharmaceuticals Trulance (plecanatide)....